{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:37:08Z","timestamp":1771061828560,"version":"3.50.1"},"reference-count":35,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,4,15]]},"DOI":"10.2169\/internalmedicine.7674-21","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T22:10:20Z","timestamp":1633385420000},"page":"1265-1270","source":"Crossref","is-referenced-by-count":10,"title":["Atypical Cogan's Syndrome Mimicking Giant Cell Arteritis Successfully Treated with Early Administration of Tocilizumab"],"prefix":"10.2169","volume":"61","author":[{"given":"Kazusato","family":"Hara","sequence":"first","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Umeda","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"},{"name":"Medical Education Development Center, Nagasaki University Hospital, Japan"},{"name":"Department of General Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Segawa","sequence":"additional","affiliation":[{"name":"Department of Radiological Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori","family":"Akagi","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushiro","family":"Endo","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Koga","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ya","family":"Kawashiri","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Ichinose","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Cogan D. Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms. Arch Ophthalmol 33: 144-149, 1945.","DOI":"10.1001\/archopht.1945.00890140064007"},{"key":"2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/00005792-198011000-00003","volume":"59","author":"BF Haynes","year":"1980","unstructured":"2. Haynes BF, Kaiser-Kupfer MI, Mason P, Fauci AS. Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine 59: 426-441, 1980.","journal-title":"Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0025-7974","issn-type":"print"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gluth MB, Baratz KH, Matteson EL, Driscoll CL. Cogan syndrome: a retrospective review of 60 patients throughout a half century. Mayo Clin Proc 81: 483-488, 2006.","DOI":"10.4065\/81.4.483"},{"key":"4","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/rheumatology\/keh228","volume":"43","author":"A Grasland","year":"2004","unstructured":"4. Grasland A, Pouchot J, Hachulla E, et al. Typical and atypical Cogan&apos;s syndrome: 32 cases and review of the literature. Rheumatology (Oxford, England) 43: 1007-1015, 2004.","journal-title":"Rheumatology","ISSN":"https:\/\/id.crossref.org\/issn\/1460-2172","issn-type":"print"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kermani TA. Takayasu arteritis and giant cell arteritis: are they a spectrum of the same disease? Int J Rheum Dis 22: 41-48, 2019.","DOI":"10.1111\/1756-185X.13288"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Raza K, Karokis D, Kitas GD. Cogan&apos;s syndrome with Takayasu&apos;s arteritis. Br J Rheumatol 37: 369-372, 1998.","DOI":"10.1093\/rheumatology\/37.4.369"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Shibuya M, Fujio K, Morita K, Harada H, Kanda H, Yamamoto K. Successful treatment with tocilizumab in a case of Cogan&apos;s syndrome complicated with aortitis. Mod Rheumatol 23: 577-581, 2013.","DOI":"10.3109\/s10165-012-0691-0"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kawasaki Y, Uehara T, Kawana S. Cutaneous vasculitis in Cogan&apos;s syndrome: a report of two cases associated with chlamydia infection. J Nippon Med Sch 85: 172-177, 2018.","DOI":"10.1272\/jnms.JNMS.2018_85-25"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Morinaka S, Takano Y, Tsuboi H, Goto D, Sumida T. Familial HLA-B<sup>*<\/sup>52 vasculitis: maternal, atypical Cogan&apos;s syndrome with Takayasu arteritis-mimicking aortitis and filial takayasu arteritis. Intern Med 59: 1899-1904, 2020.","DOI":"10.2169\/internalmedicine.4067-19"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Mekinian A, Resche-Rigon M, Comarmond C, et al. Efficacy of tocilizumab in Takayasu arteritis: multicenter retrospective study of 46 patients. J Autoimmun 91: 55-60, 2018.","DOI":"10.1016\/j.jaut.2018.04.002"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Nakaoka Y, Isobe M, Tanaka Y, et al. Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study. Rheumatology (Oxford, England) 59: 2427-2434, 2020.","DOI":"10.1093\/rheumatology\/kez630"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Nakaoka Y, Isobe M, Takei S, et al. Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study). Ann Rheum Dis 77: 348-354, 2018.","DOI":"10.1136\/annrheumdis-2017-211878"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Villiger PM, Adler S, Kuchen S, et al. Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet 387: 1921-1927, 2016.","DOI":"10.1016\/S0140-6736(16)00560-2"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Stone JH, Tuckwell K, Dimonaco S, et al. Trial of tocilizumab in giant-cell arteritis. N Engl J Med 377: 317-328, 2017.","DOI":"10.1056\/NEJMoa1613849"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33: 1122-1128, 1990.","DOI":"10.1002\/art.1780330810"},{"key":"16","unstructured":"16. Riente L, Taglione E, Berrettini S. Efficacy of methotrexate in Cogan&apos;s syndrome. J Rheumatol 23: 1830-1831, 1996."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Hautefort C, Loundon N, Montchilova M, Marlin S, Garabedian EN, Ulinski T. Mycophenolate mofetil as a treatment of steroid dependent Cogan&apos;s syndrome in childhood. Int J Pediatr Otorhinolaryngol 73: 1477-1479, 2009.","DOI":"10.1016\/j.ijporl.2009.06.025"},{"key":"18","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3109\/01676830.2013.764324","volume":"32","author":"FL Shahid","year":"2013","unstructured":"18. Shahid FL, Mukherjee R, Knapp C. Cogan&apos;s syndrome associated with orbital inflammation. Orbit 32: 206-207, 2013.","journal-title":"Orbit","ISSN":"https:\/\/id.crossref.org\/issn\/0167-6830","issn-type":"print"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Allen NB, Cox CC, Cobo M, et al. Use of immunosuppressive agents in the treatment of severe ocular and vascular manifestations of Cogan&apos;s syndrome. Am J Med 88: 296-301, 1990.","DOI":"10.1016\/0002-9343(90)90157-9"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Watanabe K, Nishimaki T, Yoshida M, et al. Atypical Cogan&apos;s syndrome successfully treated with corticosteroids and pulse cyclophosphamide therapy. Fukushima J Med Sci 46: 49-54, 2000.","DOI":"10.5387\/fms.46.49"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Fricker M, Baumann A, Wermelinger F, Villiger PM, Helbling A. A novel therapeutic option in Cogan diseases? TNF-alpha blockers. Rheumatol Int 27: 493-495, 2007.","DOI":"10.1007\/s00296-006-0252-y"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Matteson EL, Choi HK, Poe DS, et al. Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study. Arthritis Rheum 53: 337-342, 2005.","DOI":"10.1002\/art.21179"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Orsoni JG, Lagana B, Rubino P, Zavota L, Bacciu S, Mora P. Rituximab ameliorated severe hearing loss in Cogan&apos;s syndrome: a case report. Orphanet J Rare Dis 5: 18, 2010.","DOI":"10.1186\/1750-1172-5-18"},{"key":"24","unstructured":"24. Smolen JS, Landewe RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis 79: 685-699, 2020."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Verhoeven MM, de Hair MJ, Tekstra J, et al. Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials. Ann Rheum Dis 78: 1333-1338, 2019.","DOI":"10.1136\/annrheumdis-2019-215304"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Singer O. Cogan and Bechet syndromes. Rheum Dis Clin North Am 41: 75-91, viii, 2015.","DOI":"10.1016\/j.rdc.2014.09.007"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Le N, Vickers A, Prospero Ponce C, Chevez-Barrios P, Lee AG. Vestibulocochlear symptoms as the initial presentation of giant cell arteritis. Can J Ophthalmol 54: e1-e3, 2019.","DOI":"10.1016\/j.jcjo.2018.04.006"},{"key":"28","doi-asserted-by":"crossref","first-page":"ii63","DOI":"10.1093\/rheumatology\/kex428","volume":"57","author":"I Vodopivec","year":"2018","unstructured":"28. Vodopivec I, Rizzo JF 3rd. Ophthalmic manifestations of giant cell arteritis. Rheumatology (Oxford, England) 57: ii63-ii72, 2018.","journal-title":"Rheumatology","ISSN":"https:\/\/id.crossref.org\/issn\/1460-2172","issn-type":"print"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Awh C, Reichstein DA, Thomas AS. A case of giant cell arteritis presenting with nodular posterior scleritis mimicking a choroidal mass. Am J Ophthalmol Case Rep 17: 100583, 2020.","DOI":"10.1016\/j.ajoc.2019.100583"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Erdogan M, Sayin N, Yildiz Ekinci D, Bayramoglu S. Bilateral posterior scleritis associated with giant cell arteritis: a case report. Ocul Immunol Inflamm 26: 1244-1247, 2018.","DOI":"10.1080\/09273948.2017.1343854"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Cavallini GM, Volante V, Bigliardi MC, Mascia MT, Forlini M. Bilateral posterior scleritis as a presenting manifestation of giant cell arteritis: a case report. Can J Ophthalmol 49: e141-e143, 2014.","DOI":"10.1016\/j.jcjo.2014.08.015"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Jennette JC. Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Clin Exp Nephrol 17: 603-606, 2013.","DOI":"10.1007\/s10157-013-0869-6"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Emilie D, Liozon E, Crevon MC, et al. Production of interleukin 6 by granulomas of giant cell arteritis. Hum Immunol 39: 17-24, 1994.","DOI":"10.1016\/0198-8859(94)90096-5"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Park MC, Lee SW, Park YB, Lee SK. Serum cytokine profiles and their correlations with disease activity in Takayasu&apos;s arteritis. Rheumatology (Oxford, England) 45: 545-548, 2006.","DOI":"10.1093\/rheumatology\/kei266"},{"key":"35","unstructured":"35. Kong X, Sun Y, Ma L, et al. The critical role of IL-6 in the pathogenesis of Takayasu arteritis. Clin Exp Rheumatol 34: S21-S27, 2016."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/8\/61_7674-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:11:53Z","timestamp":1715231513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/8\/61_7674-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,15]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7674-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,15]]},"article-number":"7674-21"}}